These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 730827)

  • 1. Factors affecting production of catalase by Bacteroides.
    Wilkins TD; Wagner DL; Veltri BJ; Gregory EM
    J Clin Microbiol; 1978 Nov; 8(5):553-7. PubMed ID: 730827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New medium for selection and presumptive identification of the Bacteroides fragilis group.
    Livingston SJ; Kominos SD; Yee RB
    J Clin Microbiol; 1978 May; 7(5):448-53. PubMed ID: 659574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulated strains of Bacteroides fragilis in clinical specimens.
    Lindberg AA; Berthold P; Nord CE; Weintraub A
    Med Microbiol Immunol; 1979 Mar; 167(1):29-36. PubMed ID: 440201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of the subspecies of Bacteroides fragilis.
    Blazevic DJ
    Antimicrob Agents Chemother; 1976 Mar; 9(3):481-4. PubMed ID: 1259403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reliable test for differentiation and presumptive identification of certain clinically significant anaerobes.
    Hansen SL; Stewart BJ
    Am J Clin Pathol; 1978 Jan; 69(1):36-40. PubMed ID: 339709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Selective Medium for Isolation of Bacteroides fragilis from Clinical Specimens.
    Ho PL; Ho LY; Yau CY; Tong MK; Chow KH
    J Clin Microbiol; 2017 Feb; 55(2):384-390. PubMed ID: 27852672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples.
    Tong J; Liu C; Summanen P; Xu H; Finegold SM
    Anaerobe; 2011 Apr; 17(2):64-8. PubMed ID: 21439390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancer.
    Namavar F; Theunissen EB; Verweij-Van Vught AM; Peerbooms PG; Bal M; Hoitsma HF; MacLaren DM
    J Med Microbiol; 1989 Jul; 29(3):171-6. PubMed ID: 2746627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid identification of clinically important bacteroides by coagglutination method.
    Lalitha MK; Anandi V; Elias L; Kalpana CR
    Indian J Med Res; 1991 Mar; 93():98-102. PubMed ID: 1855827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent antibody test kit for rapid detection and identification of members of the Bacteroides fragilis and Bacteroides melaninogenicus groups in clinical specimens.
    Holland RW; Stauffer LR; Altemeier WA
    J Clin Microbiol; 1979 Aug; 10(2):121-7. PubMed ID: 41847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase in Bacteroides fragilis and related Bacteroides species.
    Carlsson J; Wrethén J; Beckman G
    J Clin Microbiol; 1977 Sep; 6(3):280-4. PubMed ID: 332713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of Bacteroides fragilis group from clinical specimens following antimicrobial therapy.
    Brook I; Frazier EH
    Can J Microbiol; 1992 Mar; 38(3):226-9. PubMed ID: 1393825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endotoxin production in members of the Bacteroides fragilis group in relation to colorectal cancer humans].
    Chmelar D; Vrtný J
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):97-102. PubMed ID: 20640988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice.
    Walker CB; Wilkins TD
    Infect Immun; 1976 Sep; 14(3):721-5. PubMed ID: 965094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of a fecal mutagen by Bacteroides spp.
    Van Tassel RL; MacDonald DK; Wilkins TD
    Infect Immun; 1982 Sep; 37(3):975-80. PubMed ID: 7129639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute appendicitis and Bacteroides fragilis.
    Pieper R; Kager L; Lindberg AA; Nord CE
    Scand J Infect Dis Suppl; 1979; (19):92-7. PubMed ID: 379991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of Bacteroides fragilis group susceptibility patterns in Canada.
    Bourgault AM; Lamothe F; Hoban DJ; Dalton MT; Kibsey PC; Harding G; Smith JA; Low DE; Gilbert H
    Antimicrob Agents Chemother; 1992 Feb; 36(2):343-7. PubMed ID: 1605600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.